Polimorfismos en los genes de adiponectina (RS1501299) y de su receptor 2 (RS767870) asociados al síndrome metabólico

Abstract

Background: Adiponectin stimulates fatty acid oxidation, reduces triglycerides, improves glucose metabolism and exerts a protective effect on blood vessels due to its effect anti-inflammatory and anti-atherogenic. Variation in the ADIPOQ and ADIPOR2 genes have been associated with increased risk of developing metabolic syndrome (MS), type-2 diabetes (T2D), or coronary heart disease.